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The redox-regulated chaperone Hsp33 protects
organisms against oxidative stress that leads to
protein unfolding. Activation of Hsp33 is triggered
by the oxidative unfolding of its own redox-sensor
domain, making Hsp33 a member of a recently
discovered class of chaperones that require partial
unfolding for full chaperone activity. Herewe address
the long-standing question of how chaperones rec-
ognize client proteins. We show that Hsp33 uses its
own intrinsically disordered regions to discriminate
between unfolded and partially structured folding
intermediates. Binding to secondary structure ele-
ments in client proteins stabilizes Hsp33’s intrinsi-
cally disordered regions, and this stabilization
appears to mediate Hsp33’s high affinity for struc-
tured folding intermediates. Return to nonstress con-
ditions reduces Hsp33’s disulfide bonds, which then
significantly destabilizes the bound client proteins
and in doing so converts them into less-structured,
folding-competent client proteins of ATP-dependent
foldases. We propose a model in which energy-inde-
pendent chaperones use internal order-to-disorder
transitions to control substrate binding and release.INTRODUCTION
Molecularchaperonesare involved inmaintaininga functionalpro-
teome (Tyedmers et al., 2010). Divided into various unrelated yet
highly conserved protein families, chaperones have in common
theability tobindunfoldedpolypeptidesandprevent their nonspe-
cific aggregation. Many chaperones, including the DnaK/DnaJ/
GrpE system, are classifiedas ‘‘foldases’’ as theypromote protein
folding inanATP-dependent process. Theother categoryof chap-
erones is ‘‘holdases.’’ They include stress-specific chaperones
that are needed to protect proteins against aggregation under
distinct stress situations (Haslbeck et al., 2005; Jakob et al.,1999).UsuallyATP independent, holdasesbind tightly tounfolding
proteins until nonstress conditions resume. Then, client proteins
are released for refolding in a process that is often mediated by
foldases (Haslbeck et al., 2005; Hoffmann et al., 2004).
The highly conserved, redox-regulated Hsp33 is a stress-
specific holdase,whichprotectsbacteria against severeoxidative
stress conditions, including bleach treatment (Winter et al., 2005,
2008). Under nonstress conditions, Hsp33 is a compactly folded
zinc-binding protein with negligible affinity for unfolded proteins.
However, when exposed to oxidative stress conditions that lead
to widespread protein unfolding, Hsp33 undergoesmassive con-
formational rearrangements. These changes occur via Hsp33’s
C-terminal redox-switch domain, which consists of an50 amino
acid (aa) flexible linker region (aa 178–231) and an adjacent,
redox-sensitive zinc center. Triggered by oxidative disulfide
bond formation and zinc release, the redox-switch domain of
Hsp33 unfolds (Graf et al., 2004; Ilbert et al., 2007). That activation
of Hsp33 requires its unfolding makes Hsp33 a member of a new
class of chaperones that are active when intrinsically disordered
(Tompa and Csermely, 2004). Previous studies revealed that the
specific activation of Hsp33 compensates for the inactivation of
ATP-dependent folding chaperones, which are unable to function
efficiently due to the oxidative stress-mediated drop in intracel-
lular ATP levels (Winter et al., 2005). Release of client proteins
fromHsp33 requires restoration of reducing nonstress conditions
and the presence of a functional DnaK system (Hoffmann et al.,
2004). Analysis of the in vivo substrate-binding specificity of
Hsp33 and DnaK revealed an extensive overlap in client proteins,
a necessary prerequisite for the synergistic action of the two
classes of chaperones (Winter et al., 2005).
Activation of Hsp33 requires its native unfolding, making Hsp33
a particularly intriguing example of a protein that apparently needs
to lose its structure to gain function. Several other chaperones,
including the acid-activated HdeA (Tapley et al., 2009) and the
heat-activated small heat shock proteins (Jaya et al., 2009), have
been shown to use localized protein unfolding for activation. In
addition, many other chaperones have been shown to constitu-
tively contain regions of intrinsic disorder (Tompa and Csermely,
2004). Due to a lack of structural information about chaperone-
substrate complexes and intrinsically disordered proteins in
general, little is known about the precise roles played by theseCell 148, 947–957, March 2, 2012 ª2012 Elsevier Inc. 947
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Figure 1. Peptide-Binding Specificity of
Active Hsp33ox
(A) A peptide array was incubated with inactive
Hsp33 (Hsp33red) or active Hsp33 (Hsp33ox), and
Hsp33 was visualized with Cy5-fluorescently
labeled anti-Hsp33 antibodies. False-color
imaging of the signal intensities ranges from blue
(no binding) to red (maximal binding). The order of
overlapping peptides in the array, including
normalized binding scores, is shown for select
NuoCD peptides. Sequences of peptides that
comprise the good binder PepNuoC are shown in
bold red.
(B–D) Relative amino acid occurrence (B), net
charge (C), and hydrophilicity (D) in good binders
(red) and nonbinders (blue) were calculated and
normalized to the occurrence of the same amino
acid or feature distribution in the entire library. A
value of 100% indicates that occurrence of a
specific amino acid is identical to occurrence in the
total peptide library.
See also Figure S1 and Table S1.regions. Here we used a combination of peptide-binding analysis,
measurements of protein stability by rates of hydrogen/deuterium
(H/D) exchange and mass spectrometry, and limited proteolysis
studies to demonstrate that chaperones, like Hsp33, use their
intrinsically disordered regions to specifically recognize early un-
folding intermediates and trigger unfolding processes necessary
to return proteins onto a productive folding pathway.
RESULTS
Identification of Hsp33’s Peptide-Binding Specificity
We were intrigued by the question of how Hsp33 can effectively
bind hundreds of different client proteins while studiously avoid-
ing binding to its own intrinsically disordered C-terminal redox-
switch domain, even though this domain is unfolded and present
at very high local concentrations. We thus decided to determine
the substrate-binding specificity of Hsp33by screening apeptide
array comprised of 3,914 peptides, encompassing the complete
sequences of 18 different proteins (Table S1 available online).
A large subset of these peptides was derived from previously
identified Hsp33 and DnaK client proteins (Ru¨diger et al., 1997;
Winter et al., 2008). We used 12-mer peptides spanning the
entire sequence of the individual proteins. Each peptide overlap-
ped the adjacent peptide by 10 residues.
The peptides were synthesized in situ on microfluidic chips
and immobilized via a long (equivalent to 30 aa) C-terminal poly-
ethylene glycol linker (Pellois et al., 2002). As shown in Figure 1A,
in contrast to reduced, inactive Hsp33red, which did not reveal
significant binding, active Hsp33ox bound strongly to select
sets of overlapping peptides (i.e., repetitive binding). We normal-
ized and scored the fluorescence intensities from 0 to 1 accord-
ing to a flow scheme depicted in Figure S1A (see Experimental948 Cell 148, 947–957, March 2, 2012 ª2012 Elsevier Inc.Procedures for details). Peptides that bound to at least three
directly adjacent peptides with individual scores of R0.8 were
defined as ‘‘good binders,’’ whereas peptides with at least three
repetitive low scores of%0.2 were defined as ‘‘nonbinders.’’
To assess the peptide-binding specificity of Hsp33ox, we
determined the relative occurrence of amino acids in good
binders versus nonbinders compared to the relative occurrence
of all 20 amino acids in the total peptide library. We found only
a few amino acids that were slightly more abundant in good
binders (Figure 1B, red) and less abundant in nonbinders (Fig-
ure 1B, blue) as compared to the total peptide library. In contrast,
however, we found that the two negatively charged residues Asp
and Glu, as well as Trp, Cys, and Lys, were strongly disfavored in
good binders and highly enriched in peptides that failed to bind
to Hsp33 (Figure 1B). Analysis of the amino acid sequence in
either good binders or nonbinders did not reveal any specific
sequence motif or position specificity for any of these residues
(Figure S1B). However, Hsp33-peptide interactions appeared
to largely depend on net charge and hydrophobicity of the
peptides, with nonbinding peptides being significantly more
acidic and less hydrophobic than good binders (Figures 1C,
1D, and S1B). To predict Hsp33-binding sites in proteins, we
developed an algorithm that takes amino acid distribution,
hydrophobicity, net charge, and secondary structure into
account (see Extended Experimental Procedures). This algo-
rithm showed high accuracy in predicting good binders (83%)
and nonbinders (91%) of Hsp33.
Validation of Hsp33’s Peptide-Binding Specificity
in Solution
To validate the peptide array binding results in solution assays,
we synthesized PepNuoC, a 25 aa peptide exhibiting one of the
Figure 2. Validation of Peptide Binding in
Solution and KD Measurements
(A) Competitor activity of PepNuoC was assessed
by determining its ability to compete with
0.075 mM chemically unfolded CS for binding to
0.15 mM Hsp33ox or 0.375 mM DnaK/0.075 mM
DnaJ. Complexes between chaperones and
competitors were allowed to form for 4 min before
chemically denatured CS was added. Light-scat-
tering measurements of CS at 30C were con-
ducted as read-out for competitor activity. The
light-scattering signal of CS in the presence of fully
active chaperones (i.e., absence of competitor)
was set to 0% competitor activity, whereas the
light-scattering signal of CS in the absence of
functional chaperone (i.e., full competition) was
set to 100%. Presence of PepNuoC had no signifi-
cant influence on the aggregation behavior of CS
in the absence of chaperones.
(B) SPR sensorgrams to monitor interactions
between Hsp33ox or Hsp33red and immobilized
PepNuoC or oxidized Hsp33C-term. The data were
fitted (black symbols) using BIAevaluation soft-
ware.
(C) Competitor activity of predicted Hsp33 good
binder peptides and nonbinder peptides was
assessed by determining their ability to compete
with 0.075 mM chemically unfolded CS for binding
to 0.15 mM Hsp33ox. Light-scattering measure-
ments were conducted as described above. The
upper panel illustrates the NMR structures of
the respective peptides according to PDB
(Table S2B). Far-UV CD spectroscopy revealed an
a helix for Pep1 and random coils for Pep6–8 (see
Figure S2D).
See also Figure S2 and Table S2.highest scores in our peptide array over seven repeats (Figure 1A,
right panel). To assess whether PepNuoC binds to Hsp33ox in
solution, we determined its competitive activity by measuring
how increasing amounts of PepNuoC influence the ability of active
Hsp33ox to suppress the aggregation of chemically unfolded
citrate synthase (CS), a known substrate of Hsp33 (Figure 2A).
We found that the ability of activated Hsp33ox to prevent CS
aggregation diminished with increasing amounts of PepNuoC,
implying that this peptide functions as Hsp33 substrate also
in solution. To determine the precise affinity of Hsp33ox for
PepNuoC, we conducted surface plasmon resonance (SPR)
experiments in which we immobilized PepNuoC on a chip (Fig-
ure 2B). Whereas Hsp33red failed to bind to the peptide even at
the highest concentration used (i.e., 750 nM), Hsp33ox showed
specific binding with a dissociation constant (KD) of 35 ± 0.6 nM
per active Hsp33 dimer (Figures 2B and S2A and Table S2A).
Note that this KD is very similar to the KD values (30–300 nM)
that were previously determined using the SUPREX technique
to quantify binding of Hsp33ox to thermally unfolded CS (Xu
et al., 2010). Taken together, these results strongly suggestthat PepNuoC and full-length substrates share the same binding
site in Hsp33.
Several other high-affinity peptides of Hsp33ox identified by
the array turned out to be insoluble upon synthesis. We thus
decided to use a complementary approach to validate our
peptide array results. We reasoned that our prediction algorithm,
if accurate, should identify good binders and nonbinders of
Hsp33 from a list of commercially available, soluble peptides.
We scored 670 commercially available peptides for Hsp33
binding and screened the peptides against a database of
peptides for which nuclear magnetic resonance (NMR) struc-
tures have been solved. By using this approach, we would be
able to test our binding predictor and gain access to atomic
resolution structures of potentially binding and nonbinding
peptides. Whereas the NMR structures of many of our predicted
good binders had been solved, none of our predicted nonbinders
had structures available. We obtained six predicted good
binders with known structures as well as two nonbinders (Table
S2B) and tested their competitive activity in our chaperone assay
(Figure 2C). All but one of the predicted good binders (i.e., Pep6,Cell 148, 947–957, March 2, 2012 ª2012 Elsevier Inc. 949
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Figure 3. Hsp33 and DnaK Show Distinct
Peptide-Binding Specificity
(A) Comparison of secondary structure features in
good binders and nonbinders of Hsp33ox with
good binders of DnaK. Analysis of DnaK’s non-
binders was not possible due to the semi-
quantitative nature of the cellulose peptide array
used to collect this data (Ru¨diger et al., 1997).
(B) Influence of 0.325 mM Hsp33C-term or a-casein
on the ability of 0.13 mM active Hsp33ox or 0.65 mM
DnaK /0.13 mM DnaJ to suppress the aggregation
of 0.065 mM chemically denatured luciferase at
30C. Competitor activity was determined as
described above.
(C) Time course of Arc unfolding and competitor
activity. Arc unfolding was initiated by diluting Arc
(0.75 mM) into HEPES buffer (pH 7.5) at 30C. At
distinct time points after start of the unfolding
process, 0.15 mM active Hsp33ox or 0.187 mM
DnaK/0.075 mMDnaJ was added to allow complex
formation. After 10 s, 0.075 mM chemically
unfolded CS was added. Light scattering of CS
was monitored and competitor activity of Arc was
determined as described above. Inset: Unfolding
of 0.75 mM Arc was monitored by following the
fluorescence of its single tryptophan residue
located at the monomer-monomer interface upon
dilution into buffer. Arrows indicate the time points
at which Arc was analyzed for competitor activity.
See also Figure S3.see below) prevented Hsp33ox from suppressing CS aggrega-
tion in a concentration-dependent manner, indicating that they
interact with active Hsp33 (Figures 2C and S2C). The peptide
with the apparently highest affinity to Hsp33 was Pep1 (i.e.,
neuropeptide Y), which fully competed with full-length CS for
binding to Hsp33 at a Pep1 to CS ratio of 5:1. In contrast, none
of our predicted nonbinder peptides (Pep7, Pep8) competed
with CS for binding to Hsp33 even when present in 100-fold
excess to CS (Figure 2C). These results strongly suggest that
the peptide-binding specificity as determined in our peptide
array and used as dataset for our binding predictor reflects
well the binding specificity of active Hsp33 in solution.
Hsp33 Avoids Self-Binding by Disfavoring Natively
Unfolded Polypeptides
Peptide-binding analysis revealed that Hsp33’s substrate recog-
nition might rely more on the chemical and structural features of
the amino acids and peptides than on specific amino acid
sequence motifs. It was furthermore intriguing to observe that
overrepresentation of the same amino acids that are abundant
in Hsp33’s nonbinders characteristically defines natively disor-
dered segments (Prilusky et al., 2005). In fact, all of the amino
acids that Hsp33ox excludes from binding, i.e., Asp, Glu, Cys,
and Lys, are highly enriched in natively unfolded proteins,
including Hsp33’s own C-terminal redox-switch domain (Fig-
ure S1C). These results suggested that Hsp33 avoids self-
binding by disfavoring binding to natively disordered regions.
Localization analysis of our nonbinders and good binders in
the available crystal structures of the tested proteins fully agreed
with these conclusions and revealed that 59% of nonbinders are
indeed found in loops and nonstructured regions. In contrast, the950 Cell 148, 947–957, March 2, 2012 ª2012 Elsevier Inc.majority (76%) of Hsp33’s good binders are located in the struc-
tured regions of the proteins (Figure 3A), suggesting that Hsp33
might require secondary structure elements for binding. Al-
though it is experimentally difficult to assess whether secondary
structures persist within the dense spots of individual 12-mer
peptides on the array, secondary structure elements are known
to occur in peptides as short as 12 aa (Voelz et al., 2009). More-
over, our peptide-binding studies shown in Figure 2C were
entirely consistent with this model. All five of our Hsp33-binding
peptides (Pep1–5) contained significant amounts of secondary
structure as illustrated by their NMR structures (Figure 2C) and
confirmed for Pep1 by far-UV circular dichroism (CD) spectros-
copy (Figure S2D). In contrast, far-UV CD spectra of our non-
binding peptides (Pep6–8) revealed that they are predominantly
random coil in aqueous solution (Figure S2D; Table S2C). This
included Pep6 (i.e., obestatin), the only predicted good binder
of Hsp33 that failed to compete with CS for binding to active
Hsp33ox. Protein Data Bank (PDB) searches revealed that
Pep6 is a helical when present in micelles yet adopts random-
coil structure in water (Figures 2C and S2D). It thus appears
that our predictor identified this peptide as a potentially good
Hsp33 binder based on the fact that this peptide has secondary
structure-forming potential. The peptide apparently failed to bind
to Hsp33, however, as it was unfolded in our buffer system.
To experimentally address the question of whether Hsp33ox
interacts with natively disordered proteins, we performed chap-
erone competition experiments in the presence of increasing
concentrations of its own oxidized C-terminal fragment,
Hsp33C-term (aa 218–287), which is unfolded when oxidized
(Graf et al., 2004), or a-casein, a well-established natively
unfolded protein (Gaspar et al., 2008). We found that neither
polypeptide competed with chemically unfolded luciferase (Fig-
ure 3B) or CS (Figure S3A) for Hsp33ox binding. SPR binding
experiments with the immobilized Hsp33C-term as a substrate
confirmed these results (Figure 2B). These results suggest that
Hsp33 avoids self-binding by disfavoring binding to natively
disordered regions and favoring binding to secondary structure
elements.
DnaK and Hsp33 Have Overlapping Client Proteins
but Distinct Folding-State Specificities
Our results fit well with the physiological niche that Hsp33
occupies in vivo, which is to prevent aggregation of mature
proteins that slowly unfold as cells encounter stress conditions
(Winter et al., 2005, 2008). In contrast, Hsp33’s synergistic inter-
action partner DnaK interacts with unfolded polypeptide chains
as they emerge from the ribosome (Deuerling et al., 1999).
Analysis of DnaK’s previously conducted peptide array (Ru¨diger
et al., 1997) with regard to the predicted secondary structure
features of DnaK’s high-affinity peptides agreedwith this conclu-
sion and showed that many high-affinity binding peptides of
DnaK are predicted to be localized in unstructured regions of
the substrate proteins (Figure 3A).Moreover, localization analysis
of the high-affinity binding peptides of Hsp33 and DnaK on the
primary sequences of the seven common substrate proteins
revealed that many binding sites only partially overlapped, sug-
gesting that the chaperones often recognize regions adjacent
in the primary structures of the substrate proteins (Figure S3B).
To directly compare the in vitro substrate-binding specificity
of the two chaperones, we conducted competition experiments
with DnaK in the presence of either Hsp33C-term or a-casein, the
two natively unfolded proteins that failed to interact with Hsp33ox
(Figure 3B), or PepNuoC (Figure 2A), whichwe identified as a good
binder of Hsp33ox. These experiments were conducted in the
presence of the cochaperone DnaJ, which is required tomediate
stable complex formation between DnaK and substrate proteins
(Lu and Cyr, 1998). Both natively unfolded proteins decreased
the influence of the DnaK/DnaJ system on the aggregation of
the client protein luciferase, indicating that the unfolded poly-
peptides compete for DnaK’s binding site (Figure 3B). In
contrast, however, the presence of a 20-fold molar excess of
PepNuoC only marginally affected the chaperone function of the
DnaK system, which agrees with SPR measurements that
showed that the affinity of DnaK to PepNuoC is almost 10-fold
lower than the affinity of Hsp33ox for this peptide (Figure S2A
and Table S2A). These results confirmed the preference of
DnaK for unstructured polypeptides (Deuerling et al., 1999),
including the intrinsically disordered region of activatedHsp33ox.
To obtain independent confirmation that activated Hsp33ox
and the DnaK system have the same client proteins but recog-
nize distinct structural features, we investigated their influence
on the 55 aa Arc repressor, a client protein of both chaperones
(Figure S3C). Arc has been previously shown to rapidly disso-
ciate and slowly unfold upon dilution into salt-free buffer without
forming aggregates (Figure 3C, inset) (Bowie and Sauer, 1989).
We predicted, based on our previous results, that activated
Hsp33ox should interact with more structured folding intermedi-
ates of Arc that appear early in the unfolding process of Arc,
whereas the DnaK/DnaJ system should recognize folding inter-mediates at later points during Arc’s unfolding process. We
thus added activated Hsp33ox or the DnaK/DnaJ system at
defined time points after start of Arc’s unfolding process and
allowed complexes to form before we added unfolded CS to
analyze Arc’s competitive activity. As shown in Figure 3C, the
results were in excellent agreement with our prediction. We
found that the ability of Arc to compete with CS for binding to
Hsp33ox decreased with progressing unfolding of Arc, whereas
competition for binding to the DnaK/DnaJ system increased
with increased unfolding. These results strongly support our
conclusion that the two chaperone systems share their client
proteins but exert significantly different folding-state specificity.
Intrinsically DisorderedRegions inChaperones: Flexible
Binding Sites for Structured Folding Intermediates?
Our results raised a number of intriguing conceptual questions,
particularly with regard to the mechanism by which substrate
transfer between Hsp33 and the DnaK system is coordinated
and the potential role that Hsp33’s intrinsically disordered region
might play in this process. We thus decided to directly monitor
the structural changes that Hsp33 undergoes upon substrate
binding, paying particular attention to Hsp33’s flexible linker
region and zinc-binding domain (i.e., C-terminal redox-switch
domain). In one set of experiments, we used a limited proteolysis
assay with a mass spectrometric readout to characterize the
exposed and buried regions in Hsp33 by means of their accessi-
bility to trypsin. We first used different ratios of trypsin to Hsp33
and digestion times to compare the proteolytic sensitivity of
inactive Hsp33red and active Hsp33ox in the absence of substrate
proteins. In each case, the peptides were analyzed by liquid
chromatography mass spectrometry (LC-MS) and mapped
onto the modeled structure of reduced Escherichia coli Hsp33
(Cremers et al., 2010). Under all conditions tested, we found
differential protection patterns in Hsp33red and Hsp33ox, consis-
tent with large structural rearrangements upon Hsp33’s oxida-
tive activation. Residues that were more accessible in Hsp33ox
as compared to Hsp33red were K198, which is located in the
central a5 helix of Hsp33’s metastable linker region, and R236,
located in the zinc-binding domain of Hsp33 (Figures 4A, 4B,
S4A, and S4B). These results confirmed earlier CD and fluores-
cence measurements, which provided the initial indication that
Hsp33’s linker region and zinc-binding domain unfold in
response to disulfide bond formation and zinc release (Graf
et al., 2004; Ilbert et al., 2007). We also observed increased
accessibility of R159, located in b8, the nearby R155, and K44,
a residue of the central a2 helix, upon activation of Hsp33
(Figures 4A, 4B, S4A, and S4B). These results suggest that struc-
tural changes in a5 disrupt interactions with b8, one of the four
b strands shown to be involved in linker binding in inactive
Hsp33red and thought to contribute to substrate binding in active
Hsp33ox (Cremers et al., 2010). Oxidative activation of Hsp33
also affected accessibility for three residues (i.e., K62, R126,
and R148) that are located adjacent to Hsp33’s highly conserved
monomer-monomer interface (Graumann et al., 2001), reflecting
the structural changes that accompany dimerization of oxidized
Hsp33 molecules.
To determine how substrate binding affects the conformation
of Hsp33ox, we analyzed the proteolytic accessibility of Hsp33 inCell 148, 947–957, March 2, 2012 ª2012 Elsevier Inc. 951
Figure 4. Hsp33’s Intrinsically Unfolded Linker Region Is involved in Substrate Binding
(A) Inactive Hsp33red, active Hsp33ox, and Hsp33ox in complex with thermally unfolded luciferase [Hsp33ox-S] before or after reduction with DTT ([Hsp33ox-S]red)
were digested with trypsin for 5, 10, or 15 min, and cleavage products were analyzed by LC-MS. The most accessible sites (cleaved within 5 min) are indicated in
dark red, and sites that were not cleaved within 15 min are indicated in gray. Peptides with very low abundance are indicated with a star. Color-coded secondary
structure elements of Hsp33 are shown for reference.
(B) Differences in the proteolytic patterns of Hsp33red, Hsp33ox, and Hsp33ox-substrate were mapped onto the modeled E. coli Hsp33 structure. Relative
accessibility of the individual sites is indicated by color intensity, with the most accessible residues shown in dark red and the least accessible shown in gray.
Unaltered trypsin cleavage sites are indicated in light blue. The color-coded domain structure of Hsp33 with labeled secondary structure elements is shown for
reference.
(C) Representative SUPREX curves of two fragments from the flexible linker region (aa 174–192, aa 203–221, after 5 min H/D-exchange) and one peptide from the
stable N-terminal region (aa 26–47, after 2 min H/D exchange) obtained from Hsp33red (black), Hsp33ox (red), or the Hsp33ox-CS complex (blue). Solid lines are
best fits of the data to a four-parameter sigmoidal equation, used to obtain C1/2 values (Table S3).
See also Figure S4 and Table S3.
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complex with thermally unfolded luciferase (Figures 4A and 4B)
or CS (Figure S4A). We reasoned that regions in Hsp33ox that
are either directly or indirectly involved in substrate interaction
should become more protected upon substrate binding. The
regions that we found to be affected by binding to either
substrate involved the flexible linker of Hsp33 (K198) as well as
the adjacent b8 strand and central a2 helix (Figures 4A and
4B). Accessibility of these sites (i.e., R159, K44) decreased
upon substrate binding, implying that interaction of Hsp33ox
with substrate proteins either directly obscures the cleavage
sites and/or sterically blocks trypsin from gaining access to the
sites. Other residues in Hsp33ox whose accessibility was
decreased by client protein binding were identified to be close
to Hsp33’s dimerization interface, consistent with functional
studies that showed that substrate binding stabilizes the
Hsp33 dimer (Hoffmann et al., 2004). No other region in Hsp33ox
was found to have substantially altered proteolytic behavior
upon substrate binding at this or less stringent trypsin con-
centrations. This included the zinc-binding domain, whose
proteolytic accessibility was unaltered by the presence of
substrate proteins. This result agreed with previous studies
that showed that absence of the zinc-binding domain affects
Hsp33’s redox regulation but not its ability to bind client proteins
(Ilbert et al., 2007). These results suggest that client protein
binding involves the flexible linker of Hsp33 as well as potentially
a loop region located directly underneath the central a5 helix of
Hsp33’s linker.
Limited proteolysis is a good tool to assess global conforma-
tional changes in proteins but is restricted by cleavage site
locations. We therefore decided to employ the SUPREX tech-
nique to directly compare the relative changes in thermody-
namic stability of Hsp33 upon oxidative activation and substrate
binding (Xu et al., 2010). In SUPREX, the H/D exchange proper-
ties of globally protected amide protons in a protein are probed
as a function of chemical denaturant concentration to acquire
information about a protein’s conformational stability (Xu
et al., 2010). SUPREX experiments have previously shown
that Hsp33ox is globally destabilized by 23.8 kJ/mol per dimer
upon oxidative activation and that substrate binding stabilizes
Hsp33ox by 7.1–10.0 ± 0.9 kJ/mol per dimer, depending on
the substrate protein (Tang et al., 2007). In order to map which
regions of the Hsp33 structure undergo the most significant
conformational changes upon oxidation and upon substrate
binding, we utilized the SUPREX methodology and combined
it with a pepsin digestion protocol (Xu et al., 2010). The overall
coverage of Hsp33 was 60% (Figure S4B; Table S3). A MALDI-
MS analysis was used to determine the extent of H/D exchange
(i.e., Dmass) for each peptide. Plots of Dmass versus [GdmCl]
(i.e., SUPREX curves) were generated for each peptide, which
revealed transition midpoints (i.e., C1/2 values) and initial H/D
exchange levels, used to determine sequence-specific stability
changes in Hsp33 (Table S3). In excellent agreement with our
limited proteolysis results, we found that the most dramatic
thermodynamic changes upon oxidative activation and
substrate binding take place in two regions of Hsp33, aa 174–
192 (i.e., a5) and aa 203–221 (i.e., a6–b10), which span nearly
all of Hsp33’s linker region (Figure 4C). Our thermodynamic
analyses with C1/2 value changes observed for peptides derivedfrom this region indicate that the linker region of Hsp33 is desta-
bilized upon oxidative activation, as indicated by the 0.5 to
0.8 M C1/2 value shifts that were observed for the Hsp33 (aa
174-192) and Hsp33 (aa 203-221) peptides (Figure 4C, compare
black and red data; Table S3). Notably, this region of Hsp33ox’s
structure regained some of its stability (i.e., C1/2 values were
shifted to a higher denaturant concentration) upon binding ther-
mally unfolding CS (Figure 4C, compare red and blue data;
Table S3). These results provide additional evidence that the
natively unfolded linker region of Hsp33 is directly involved in
substrate binding. The stabilization that we observed in
Hsp33’s linker region is most likely through a combination of
direct substrate binding and substrate-mediated refolding
and contributes to the overall affinity of Hsp33 for its client
proteins.
Reduction of Hsp33-Substrate Complexes Destabilizes
Bound Substrate Proteins
Release of client proteins from Hsp33ox requires the restoration
of reducing nonstress conditions and the presence of the DnaK
system (Hoffmann et al., 2004). Our studies now raise the ques-
tion of how the DnaK system is able to trigger substrate release
from Hsp33, given the only partially overlapping peptide-binding
specificity of the two chaperone systems. To address this ques-
tion, we undertook structural studies on the bound substrate
proteins primarily using SUPREX analysis of CS, both alone
and in complex with Hsp33 before and after DTT treatment.
This analysis provided region-specific stability information of
approximately 50% of the CS molecule (Figures 5A and S5A).
A comparison of the transition midpoint values (C1/2) obtained
on these peptides from native CS and thermally unfolded CS in
complex with Hsp33ox revealed that the relative thermodynamic
stabilities of several regions (helices a3, a4, a5/6, and a8/9) of the
CS structure were unchanged (Figures 5A and 5B and Table S4).
However, we identified three regions of CS involving helices
a1–a2, a12–a15, and a19–a20 that appear to be strongly desta-
bilized in the complex (Figures 5A and 5B). Importantly, these
regions coincide well with the dimerization interface of CS;
helices a12 and a13 (aa 269–298) are part of a largely hydro-
phobic, four-stranded antiparallel a helix sandwich, which
constitutes the main component of the monomer-monomer
interface of CS, whereas helices a2 (aa 57–70) and a20 (aa
453–460) contribute to dimerization by deeply burying them-
selves into the other monomer (Figure S5A). Two additional
CS peptides located near the monomer-monomer interface
containing helix a14/15 (aa 310–330, aa 325–351) were detected
in native CS but not detected in the MALDI readout of the
complex. Absence of these peptides was not due to signal
suppression effects in the MALDI readout (Figure S5B) but
presumably due to Hsp33 directly protecting these CS sites
against proteolysis (Figures 5A and 5B). These results are
remarkably consistent with our peptide array studies, which
showed high-affinity binding to peptides spanning helices a1,
a12, a13, and a15 (Figure 5B). They strongly suggested that
Hsp33ox interacts with parts of CS’s hydrophobic dimerization
interface (Figure S5A).
To assess whether reduction of the Hsp33-substrate
complex affects the conformation of CS, we treated theCell 148, 947–957, March 2, 2012 ª2012 Elsevier Inc. 953
Figure 5. Reduction of Hsp33-Substrate
Complexes Destabilizes Bound Substrate
Proteins
(A) Representative SUPREX curves of CS frag-
ments obtained from native CS (black) or thermally
unfolded CS in complex with Hsp33ox before (red)
or after (blue) complex reduction with 5 mM
DTT. Solid lines represent best fits of the data.
Secondary structure elements of CS are shown for
reference. Peptide regions that show a significant
change in relative thermodynamic stability are
indicated by red bars, whereas regions that do not
significantly change are indicated by pink bars
(see also Table S4). Regions of CS defined as
good binders by peptide array are shown by dark
cyan bars, whereas regions of CS involved in
monomer-monomer interactions are indicated by
purple bars. Stars depict active site residues.
(B) Comparison of the relative thermodynamic
stability profile of CS peptides obtained from
SUPREX analysis in native CS, in thermally
unfolded CS in complex with Hsp33ox ([Hsp33ox-
CS]), or upon DTT reduction ([Hsp33-CS]red). All
identified peptides were mapped onto the CS
structure (PDB: 2CTS), and changes in relative
thermodynamic stability are depicted as color
changes from pink to red as stability decreases.
Right panel: Localization of Hsp33’s good binders
in CS structure as defined by peptide array is de-
picted in green.
(C) Comparison of limited proteolysis profiles of
CS, MDH, or luciferase either in native form or
upon thermal unfolding in the presence of Hsp33ox
before or after reduction with DTT. Peptides de-
tected in native form and upon complex formation
are depicted in green, peptides found in complex
both before and after reduction are shown in blue,
and peptides that are only detected after complex
reduction are indicated in orange. Regions of CS
defined as good binders by peptide array are
indicated by dark cyan bars. Peptides of CS
identified in SUPREX analysis are indicated by red
and pink bars, respectively (see Figure 5A for
reference).
See also Figure S5 and Table S4.complex with DTT for 30 min ([Hsp33-S]red). This incubation is
sufficient to reduce Hsp33’s disulfide bonds (Hoffmann et al.,
2004) and causes moderate conformational rearrangements in
Hsp33, particularly in its zinc-binding domain (Figure 4A).
Importantly, complex formation is maintained unless the
DnaK system is added (Hoffmann et al., 2004). Upon reduction
of the Hsp33ox-CS complex, we found that peptides covering
the four helices a12–a15 (aa 269–351) of CS all lacked transi-
tion regions and showed significant loss in the number of glob-
ally and/or subglobally protected amide protons (Figure 5A and
Table S4). Such a loss of protected amides is most likely a result
of a significant destabilization and/or structural changes of the
monomer-monomer interface upon reduction of the Hsp33-
substrate complex. Limited proteolysis analysis of CS, MDH,
or luciferase in complex with Hsp33ox yielded qualitatively
very similar results (Figure 5C). In each case, return to non-954 Cell 148, 947–957, March 2, 2012 ª2012 Elsevier Inc.stress conditions uncovered proteolytic sites in the substrate
proteins that were inaccessible in the native substrates or
upon complex formation with Hsp33ox. Notably, thiol trapping
experiments of the thermally unfolded substrate proteins in
complex with Hsp33ox before and after complex reduction
excluded significant thiol oxidation within the substrate
proteins, implying that the conformational changes that we
observed in the client proteins are induced by Hsp33 reduction
and not by the reduction of the bound proteins. These results
strongly suggest that reduction-mediated refolding of Hsp33’s
C-terminal redox-sensor domain triggers conformational rear-
rangements in the bound proteins that are consistent with
increased substrate unfolding and the loss of stabilizing
Hsp33-substrate interactions. These appear to be the neces-
sary prerequisites for the successful transfer of folding interme-
diates to the DnaK system.
DISCUSSION
Intrinsically Disordered Regions Confer ‘‘Folding-State’’
Specificity to Substrate Binding
Hsp33 is a member of a new group of unrelated ATP-indepen-
dent chaperones, which become rapidly activated when cells
encounter particularly problematic stress conditions that cause
both widespread protein unfolding and inactivation of essential
housekeeping chaperones (Jakob et al., 1999; Tapley et al.,
2009). One common feature that these stress-specific chaper-
ones share is their ability to quickly convert large parts of their
structure into intrinsically disordered protein segments in
response to activating stress conditions. Only upon reaching
this state of native disorder, either stress-induced or by rational
design (Cremers et al., 2010), do these chaperones gain their full
substrate-binding potential. Based on the widely accepted
notion that molecular chaperones utilize distinct hydrophobic
binding sites (Tyedmers et al., 2010), it was thought that these
chaperones contain specialized hydrophobic surfaces that serve
double duty: as stabilizing interfaces for metastable protein
segments (i.e., Hsp33) or monomer-monomer interactions
(i.e., HdeA) under nonstress conditions and as high-affinity
substrate-binding sites for unfolding proteins under stress
conditions (Ilbert et al., 2007; Tapley et al., 2009). This model,
however, raised several conceptual questions, including why
these chaperones would prefer binding of unfolding substrate
proteins over interacting with their own intrinsically disordered
regions. By studying the redox-regulated chaperone Hsp33,
we have uncovered one solution to this apparent quandary.
We found that activated Hsp33 uses parts of its own intrinsically
disordered segment, an50 aa linker region, as interaction sites
for binding early protein-unfolding intermediates. By using two
unrelated methods, limited proteolysis and SUPREX analysis,
both combined with mass spectrometry, we independently
confirmed significant conformational rearrangements and stabi-
lization of this intrinsically disordered region upon interaction
with two different substrate proteins. Involving these intrinsically
disordered segments in substrate binding provides large flexi-
bility in substrate recognition without requiring sequence speci-
ficity. These results concur with previous studies on the small
heat shock protein PsHsp18-1, which showed that different
unfolded substrate proteins crosslink most strongly with amino
acids of the flexible N terminus (Jaya et al., 2009).
Our binding studies revealed that Hsp33 preferentially binds
early unfolding intermediates with residual secondary structure.
This result is consistent with the binding specificity of many other
intrinsically disordered proteins whose binding partners (shown
to be native proteins, DNA, or membranes) are thought to act
as stabilizing scaffolds that promote the refolding of the disor-
dered regions (Tompa and Csermely, 2004). Based on the
conformation-selection theory proposed for intrinsically disor-
dered proteins, it is entirely possible that secondary structure
elements, which are abundantly present in early unfolding inter-
mediates, capture native-like states of Hsp33’s linker region,
thus increasing linker stability. These results strongly suggest
that Hsp33’s high specificity for structured early unfolding inter-
mediates (i.e., folding-state specificity) is guided by their ability
to act as folding scaffolds for the intrinsically disordered linkerof Hsp33. The DnaK system, however, whose primary role is to
support the folding of nascent polypeptide chains, has a discrete
peptide-binding pocket that is well-suited to bind short extended
peptides largely devoid of secondary structure elements (Chen
et al., 2006). These results serve to illustrate how the peptide-
binding specificities of distinct classes of chaperones have
adapted to serve specific physiological needs.
Reversible Order-to-Disorder Transition Controls
Substrate Binding and Release
Holdases like Hsp33 or sHsps rely on foldases to support the
refolding of their bound substrate proteins upon return to non-
stress conditions. This raises the question as to how substrate
transfer is coordinated between these chaperone systems, given
the apparent difference in binding specificity. One model, the
‘‘entropy transfer model,’’ which was proposed by Csermely
and Tompa, states that refolding of intrinsically disordered
regions upon substrate binding might provide the entropic
energy necessary to unfold the bound substrate proteins, thus
returning them onto a more productive folding pathway (Tompa
and Csermely, 2004). However, because unfolding intermedi-
ates do not occupy discrete conformational states and are highly
prone to form insoluble aggregates, structural or thermodynamic
differences between unfolding proteins in the chaperone-free
and chaperone-bound forms are very difficult to determine.
Fortunately, the unique nature of Hsp33’s substrate-binding
and release mechanism provided us with the exciting opportu-
nity to directly compare two distinct, soluble substrate protein
populations. One population is freshly unfolded in the presence
of Hsp33ox and is protected against further protein unfolding
and aggregation but is unable to be released to and/or interact
with the DnaK system. The second population, generated upon
return of Hsp33-substrate complexes to a reducing environ-
ment, is also protected against spontaneous dissociation but is
rapidly released and refolded when the DnaK system is present.
Thermodynamic analysis and limited proteolysis studies re-
vealed substantial destabilization in the second population of
substrates. These results suggest that the same thermodynamic
linkage that exists between the redox status of Hsp33’s cyste-
ines and the stability of Hsp33’s linker region and that is respon-
sible for the unfolding of Hsp33’s linker region upon disulfide
bond formation (Ilbert et al., 2007) acts during the inactivation
process of Hsp33 and is utilized to shift the equilibrium of the
bound substrate protein toward a more unfolded, destabilized
conformation (Figure 6). Increased destabilization in the sub-
strate proteins concomitant with increased stability in the linker
region will inevitably decrease Hsp33’s affinity for the substrate
proteins, marking them for release once DnaK is present.
A similar mechanism might also apply to the acid-activated
chaperone HdeA, in which return to neutral pH triggers the
disorder-order transition of the chaperone, sufficient to cause
the slow release of substrate proteins in a folding-competent
conformation (Tapley et al., 2010). Our results provide mecha-
nistic insights into how, in the absence of ATP, interactions
between natively unfolded regions and early protein-unfolding
intermediates are used to translate environmental changes into
conformational rearrangements in the substrate proteins that
are conducive to productive refolding.Cell 148, 947–957, March 2, 2012 ª2012 Elsevier Inc. 955
Figure 6. Schematic Model of Hsp33 as an Example of Stress-Specific Intrinsically Disordered Chaperones
Hsp33 senses unfolding conditions by converting stably folded regions into intrinsically disordered segments (green and cyan), which participate directly in the
highly flexible binding of a wide variety of early unfolding intermediates. Client protein binding confers stability to intrinsically disordered regions of the chaperone.
Return to nonstress conditions further stabilizes the chaperone (cyan regions), leading to destabilization/unfolding of the bound client protein, which appears to
be necessary for substrate release and refolding by foldases. To simplify the model, the dimerization equilibrium of active Hsp33 was omitted.EXPERIMENTAL PROCEDURES
Protein Purification
Purification of wild-type Hsp33, Hsp33C-term, DnaK, and DnaJ and preparation
of inactive reduced and active HOCl-oxidized Hsp33 were conducted as
described (Graf et al., 2004; Winter et al., 2008). PepNuoC was synthesized
by Genscript and included an added tyrosine residue for peptide concentra-
tion determination. Peptides described in Table S2B were obtained from
American Peptide Company or Genscript. They were either diluted in DMSO
(Pep2–5) or in buffer (Pep1, Pep6–8). Peptide concentrations were determined
using the appropriate extinction coefficient or, in the absence of Tyr or Trp resi-
dues, were estimated based on the amount of peptide provided by the
company. Arc repressor protein was generously provided by Dr. Lewis Kay.
Screening of Peptide Array for Hsp33 Binding
The peptide library comprised of 3,914 peptides of 12 aa was synthesized by
LC Sciences using PepArray technology (Pellois et al., 2002). Hsp33 binding
was visualized with Cy5-labeled anti-Hsp33 antibodies. Details about data
analysis and the development of the Hsp33-binding predictor are described
in the Extended Experimental Procedures.
Binding Affinity Measurements with SPR
Kinetic constants for peptide binding were determined by SPR using the
ProteOn XPR36 Protein Interaction Array System (Bio-Rad) in KH2PO4 (pH 7.4)
with 0.003% surfactant P20 at 25C. PepNuoC or Hsp33C-term were immobilized
by amine coupling to the GLC sensor chip. Hsp33red or Hsp33ox were applied
at six different concentrations (0–1.5 mM) using the simultaneous application
mode. The binding sensorgrams were analyzed with BIAevaluation (Biacore).
Chaperone Competition Assays
The influence of Hsp33 or DnaK/DnaJ on the aggregation of chemically dena-
tured CS (Sigma) or luciferase (Promega) was determined as described (Graf956 Cell 148, 947–957, March 2, 2012 ª2012 Elsevier Inc.et al., 2004), using chaperone and competitor concentrations given in the
figure legends. For competition studies, chaperones were preincubated with
the competitors for 4 min (peptides), 2 min (Hsp33C-term, a-casein), or 10 s (un-
folding Arc) at 30C before CS or luciferase was added. Light scattering was
monitored in 40 mM HEPES (pH 7.5) at lex/lem of 360 nm using a Hitachi
F4500 fluorescence spectrophotometer equipped with a temperature-
controlled cuvette holder and stirrer. Competition assays with PepNuoC were
conducted in 0.003%Tween P20 to increase solubility of PepNuoC. Tryptophan
fluorescence of 0.75 mMArc was followed in 40mMHEPES (pH 7.5) to monitor
Arc unfolding. lex 295 nm, lem 332 nm, and ex/em slits of 10/5 nm were used.
Formation of Hsp33-Substrate Complexes
Complexes between Hsp33 and thermally unfolded CS, malate L-dehydroge-
nase (MDH) (Roche), or luciferase were formed as described (Xu et al., 2010).
The final Hsp33 concentration was 3–5 mM for limited proteolysis or 114–
124 mM for SUPREX.
Limited Proteolysis Coupled with LC-MS
Tryptic digests were carried out at 1:10 ratios of trypsin to protein in 40 mM
K2HPO4 (pH 7.4), 25
C. Aliquots were taken at defined time points
(0–15 min), and the digest was stopped with 10% TFA. Samples were applied
to a reverse phase C18 column (Zorbax 300SB-C18, 1 3 50 mm, 3.5 m)
coupled to a Q-TOF (Agilent) dual ESI LC-MS for peptide identification.
Peptides were eluted using a 2%–80% gradient of acetonitrile at a flow rate
of 0.3 ml/min at 30C in 15 min. The BioConfirm software (Agilent) was used
for peptide identification.
SUPREX Analysis
Detailed protocols of our SUPREX analysis are provided in the Extended
Experimental Procedures. In short, a series of H/D exchange buffers
containing 20 mM Na2DPO4, pD 7.4 and different GdmCl concentrations
were prepared. H/D exchange reactions were started by diluting proteins
1:10 into SUPREX buffers. At specified exchange times, reactions were
quenched with HCl (pH 0.9), followed by a 30 s pepsin digest. One microliter
of the digested samples was added to 9 ml matrix solution and spotted onto
a MALDI target for MS analysis. The uptake of deuterons (i.e., Dmass) was
calculated for each singly charged peptide by subtracting the undeuterated
peptide mass from the deuterated peptide mass determined in the MALDI-
TOF analysis. Ten MALDI spectra were collected at each denaturant concen-
tration, and Dmass values were averaged. SUPREX curves (plots of Dmass
versus [GdmCl]) were generated for each peptide and fitted to a four-param-
eter sigmoidal equation using a nonlinear regression routine in SigmaPlot to
obtain the C1/2 value, which represents the denaturant concentration at the
transition midpoint.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
five figures, and four tables and can be found with this article online at
doi:10.1016/j.cell.2012.01.045.
ACKNOWLEDGMENTS
We thank Dr. Ru¨diger for providing us with the raw data of the DnaK peptide
array, Drs. Yosseff and Schreiber for the use of ProteOn and the analysis soft-
ware, and Dr. Kay for purified Arc repressor protein. We thank Dr. Mayer for
running the DnaK binding predictor on the CS sequence. We are grateful to
Drs. Bardwell, Xu, and Walter for critically commenting on the manuscript.
This project was supported by National Institutes of Health grants
GM065318 to U.J. and GM084174 to M.C.F. and by the European Molecular
Biology Organization and Human Frontiers postdoctoral fellowship to D.R.
Received: May 2, 2011
Revised: October 23, 2011
Accepted: January 31, 2012
Published: March 1, 2012
REFERENCES
Bowie, J.U., and Sauer, R.T. (1989). Equilibrium dissociation and unfolding of
the Arc repressor dimer. Biochemistry 28, 7139–7143.
Chen, Z., Kurt, N., Rajagopalan, S., and Cavagnero, S. (2006). Secondary
structure mapping of DnaK-bound protein fragments: chain helicity and local
helix unwinding at the binding site. Biochemistry 45, 12325–12333.
Cremers, C.M., Reichmann, D., Hausmann, J., Ilbert, M., and Jakob, U. (2010).
Unfolding of metastable linker region is at the core of Hsp33 activation as a
redox-regulated chaperone. J. Biol. Chem. 285, 11243–11251.
Deuerling, E., Schulze-Specking, A., Tomoyasu, T., Mogk, A., and Bukau, B.
(1999). Trigger factor and DnaK cooperate in folding of newly synthesized
proteins. Nature 400, 693–696.
Gaspar, A.M., Appavou, M.S., Busch, S., Unruh, T., and Doster, W. (2008).
Dynamics of well-folded and natively disordered proteins in solution: a time-
of-flight neutron scattering study. Eur. Biophys. J. 37, 573–582.
Graf, P.C., Martinez-Yamout, M., VanHaerents, S., Lilie, H., Dyson, H.J., and
Jakob, U. (2004). Activation of the redox-regulated chaperone Hsp33 by
domain unfolding. J. Biol. Chem. 279, 20529–20538.
Graumann, J., Lilie, H., Tang, X., Tucker, K.A., Hoffmann, J.H., Vijayalakshmi,
J., Saper, M., Bardwell, J.C., and Jakob, U. (2001). Activation of the redox-
regulated molecular chaperone Hsp33—a two-step mechanism. Structure 9,
377–387.Haslbeck, M., Franzmann, T., Weinfurtner, D., and Buchner, J. (2005). Some
like it hot: the structure and function of small heat-shock proteins. Nat. Struct.
Mol. Biol. 12, 842–846.
Hoffmann, J.H., Linke, K., Graf, P.C., Lilie, H., and Jakob, U. (2004). Identifica-
tion of a redox-regulated chaperone network. EMBO J. 23, 160–168.
Ilbert, M., Horst, J., Ahrens, S., Winter, J., Graf, P.C., Lilie, H., and Jakob, U.
(2007). The redox-switch domain of Hsp33 functions as dual stress sensor.
Nat. Struct. Mol. Biol. 14, 556–563.
Jakob, U., Muse, W., Eser, M., and Bardwell, J.C. (1999). Chaperone activity
with a redox switch. Cell 96, 341–352.
Jaya, N., Garcia, V., and Vierling, E. (2009). Substrate binding site flexibility of
the small heat shock protein molecular chaperones. Proc. Natl. Acad. Sci. USA
106, 15604–15609.
Lu, Z., and Cyr, D.M. (1998). The conserved carboxyl terminus and zinc finger-
like domain of the co-chaperone Ydj1 assist Hsp70 in protein folding. J. Biol.
Chem. 273, 5970–5978.
Pellois, J.P., Zhou, X., Srivannavit, O., Zhou, T., Gulari, E., and Gao, X. (2002).
Individually addressable parallel peptide synthesis on microchips. Nat. Bio-
technol. 20, 922–926.
Prilusky, J., Felder, C.E., Zeev-Ben-Mordehai, T., Rydberg, E.H., Man, O.,
Beckmann, J.S., Silman, I., and Sussman, J.L. (2005). FoldIndex: a simple
tool to predict whether a given protein sequence is intrinsically unfolded.
Bioinformatics 21, 3435–3438.
Ru¨diger, S., Germeroth, L., Schneider-Mergener, J., and Bukau, B. (1997).
Substrate specificity of the DnaK chaperone determined by screening cellu-
lose-bound peptide libraries. EMBO J. 16, 1501–1507.
Tang, L., Hopper, E.D., Tong, Y., Sadowsky, J.D., Peterson, K.J., Gellman,
S.H., and Fitzgerald, M.C. (2007). H/D exchange- and mass spectrometry-
based strategy for the thermodynamic analysis of protein-ligand binding.
Anal. Chem. 79, 5869–5877.
Tapley, T.L., Ko¨rner, J.L., Barge, M.T., Hupfeld, J., Schauerte, J.A., Gafni, A.,
Jakob, U., and Bardwell, J.C. (2009). Structural plasticity of an acid-activated
chaperone allows promiscuous substrate binding. Proc. Natl. Acad. Sci. USA
106, 5557–5562.
Tapley, T.L., Franzmann, T.M., Chakraborty, S., Jakob, U., and Bardwell, J.C.
(2010). Protein refolding by pH-triggered chaperone binding and release. Proc.
Natl. Acad. Sci. USA 107, 1071–1076.
Tompa, P., and Csermely, P. (2004). The role of structural disorder in the
function of RNA and protein chaperones. FASEB J. 18, 1169–1175.
Tyedmers, J., Mogk, A., andBukau, B. (2010). Cellular strategies for controlling
protein aggregation. Nat. Rev. Mol. Cell Biol. 11, 777–788.
Voelz, V.A., Shell, M.S., and Dill, K.A. (2009). Predicting peptide structures in
native proteins from physical simulations of fragments. PLoS Comput. Biol.
5, e1000281.
Winter, J., Linke, K., Jatzek, A., and Jakob, U. (2005). Severe oxidative stress
causes inactivation of DnaK and activation of the redox-regulated chaperone
Hsp33. Mol. Cell 17, 381–392.
Winter, J., Ilbert, M., Graf, P.C., Ozcelik, D., and Jakob, U. (2008). Bleach
activates a redox-regulated chaperone by oxidative protein unfolding. Cell
135, 691–701.
Xu, Y., Schmitt, S., Tang, L., Jakob, U., and Fitzgerald, M.C. (2010). Thermo-
dynamic analysis of a molecular chaperone binding to unfolded protein
substrates. Biochemistry 49, 1346–1353.Cell 148, 947–957, March 2, 2012 ª2012 Elsevier Inc. 957
